IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
0.272
-0.015 (-5.07%)
At close: Feb 21, 2025, 4:00 PM
0.270
-0.001 (-0.44%)
After-hours: Feb 21, 2025, 7:58 PM EST
IN8bio Employees
IN8bio had 31 employees as of December 31, 2023. The number of employees increased by 5 or 19.23% compared to the previous year.
Employees
31
Change (1Y)
5
Growth (1Y)
19.23%
Revenue / Employee
n/a
Profits / Employee
-$1,028,226
Market Cap
19.68M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 31 | 5 | 19.23% |
| Dec 31, 2022 | 26 | 7 | 36.84% |
| Dec 31, 2021 | 19 | 5 | 35.71% |
| Dec 31, 2020 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
INAB News
- 8 days ago - IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML - GlobeNewsWire
- 11 days ago - IN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia Patients - GlobeNewsWire
- 2 months ago - IN8bio Reports Continued Progression-Free Survival in Phase 1 Investigator-Sponsored Trial of INB-100 Allogeneic Gamma-Delta T Cells for Leukemias at the 2024 American Society of Hematology Annual Meeting - GlobeNewsWire
- 3 months ago - IN8bio Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 6 months ago - IN8bio Announces Clinical Pipeline Prioritization to Focus on INB-100 for Acute Myeloid Leukemia - GlobeNewsWire
- 6 months ago - IN8bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 6 months ago - IN8bio Solidifies Position as a Clinical Leader of Gamma-Delta T Cell Therapy in Oncology with 100% of Treated AML Patients in Complete Remission and Receives FDA Guidance for Registrational Trial of INB-100 - GlobeNewsWire
- 8 months ago - IN8bio to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference - GlobeNewsWire